Three Questions For FDA
June 24, 2008
After listening to last week’s press conferences by the FDA and CDC, three questions came to mind: 1) Why does the FDA establish policies that
After listening to last week’s press conferences by the FDA and CDC, three questions came to mind: 1) Why does the FDA establish policies that
Our extensive coverage of the Salmonella Saintpaul Tomato Outbreak has brought many letters including those from organizations not at all involved with tomatoes: I, for
Producing this Perishable Pundit is a lot of work and much of it is thankless. We try to give clear-headed assessments of issues and events
The other day, we did a piece entitled, Some Advice For CDC And FDA. In the article we basically raised two points. First, that FDA
We’ve run a series of pieces detailing the struggle of Mexican tomato growers to get the same treatment Florida has… an “exemption” for those parts
As one looks at the numbers, one wonders if this is actually a single outbreak. Right from the beginning, there was something curious about this
A hat tip to Dan Cohen of Maccabee Seed Co. for sending along a USA Today article by Elizabeth Weise that we think is a
The FDA has expanded its list of places in Mexico that “HAVE NOT BEEN ASSOCIATED WITH THE OUTBREAK” to including the following Mexican states: Aguascalientes,
The FDA and CDC have held a series of conference calls and press conferences during the Salmonella Saintpaul outbreak and most are rather predictable. Yet
Perhaps our biggest Pundit Peeve with this whole Salmonella Saintpaul/Tomato problem has been the lack of clarity with which CDC and FDA chooses to communicate
